SHARPIN overexpression promotes TAK1 expression and activates JNKs and NF-κB pathway in Mycosis Fungoides

Biao Chen1, Yan Zheng1, Jingna Zhu1

  • 1Department of Dermatology, Cosmetology and Venereology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.

Experimental Dermatology
|August 29, 2019
PubMed

Insights

Shank-associated RH domain-interacting protein (SHARPIN) upregulation correlates with poor prognosis in Mycosis Fungoides (MF), a type of cutaneous T-cell lymphoma (CTCL). SHARPIN activates key signaling pathways, promoting MF cell growth and spread.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Mycosis Fungoides (MF) is the most common cutaneous T-cell lymphoma (CTCL).
  • Shank-associated RH domain-interacting protein (SHARPIN) is implicated in tumor development, but its role in MF is unknown.
  • The c-Jun N-terminal kinases (JNKs) pathway is dysregulated in CTCL, yet its specific role in MF and its relationship with SHARPIN remain unclear.

Purpose of the Study:

  • To investigate the clinical significance of SHARPIN in MF.
  • To elucidate the relationship between SHARPIN and the JNKs pathway in MF.
  • To determine the molecular mechanisms by which SHARPIN influences MF progression.

Main Methods:

  • Analysis of SHARPIN expression in MF patients and correlation with prognosis.
  • In vitro studies using the MF cell line MyLa2059.
  • Investigation of SHARPIN's effects on signaling pathways including JNKs, NF-κB, p38, and TAK1.

Main Results:

  • Upregulated SHARPIN expression is associated with poor prognosis in MF patients.
  • SHARPIN expression and JNKs pathway activation are increased in MF cells (MyLa2059).
  • SHARPIN induces transforming growth factor β activated kinase-1 (TAK1) transcription, activating JNKs and NF-κB pathways.
  • SHARPIN independently promotes p38 signaling, leading to increased cell proliferation, migration, and invasion, while inhibiting apoptosis in MyLa2059 cells.

Conclusions:

  • SHARPIN upregulation is a potential biomarker for poor prognosis in MF.
  • SHARPIN plays a significant role in MF development by activating JNKs, NF-κB, and p38 signaling pathways.
  • Targeting SHARPIN or its downstream pathways may offer therapeutic strategies for MF.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.8K
Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR13:04

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Traditional cDNA-based overexpression techniques have a limited applicability for the overexpression of long noncoding RNAs due to their multiple splice forms with potential functionality. This review reports a protocol using CRISPR technology to overexpress multiple splice variants of a long noncoding...
9.3K
NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Here, we present a protocol to quickly and easily measure nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation in cell lines expressing NF-κB::luciferase reporter constructs, via measurements of luminescence in the cell lysate. Additionally, gene expression is determined via RT-qPCR isolated from cells infected with Salmonella...
11.2K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

This protocol describes caspase Bimolecular Fluorescence Complementation (BiFC); an imaging-based method that can be used to visualize induced proximity of initiator caspases, which is the first step in their...
9.4K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

MALT1 regulates innate immunity but how this occurs remains ill-defined. We used the selective MALT1 paracaspase inhibitor MLT-827 to unravel the contribution of MALT1 to innate signaling downstream of Toll-like or C-type lectin-like receptors, demonstrating that MALT1 regulates the production of myeloid cytokines, and downstream of C-type lectin-like receptors,...
7.9K